Related Experiment Video
Updated: Jun 16, 2026

Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
[Surgical treatment of head and neck chondrosarcomas]
Sergio Obeso1, José Luis Llorente, Juan Pablo Díaz-Molina
1Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Oviedo, España.
Introduction:
Head and neck chondrosarcomas may adopt different locations and biological behaviour.
Material And Method:
We present a retrospective clinical series of 17 chondrosarcomas surgically treated in our Department from 1977 until 2006.
Results:
Chondrosarcomas were located in the nasosinusal area (n=6), larynx (n=5), petrous bone (n=3), atlas (n=1), parapharyngeal space (n=1) and trachea (n=1). All patients except for one underwent surgery with radical intention. The mean follow-up period was 84 months (median, 71 months). Six patients developed recurrent disease with a mean latency of 10 months. Two patients died due to the disease and two remained alive with evidence of tumour. Patients with grade I chondrosarcomas presented less recurrent disease than those with grade II or III chondrosarcomas (17% versus 80%, P=0.029). The estimated 5-year survival was 88% with the better survival of patients with grade I chondrosarcomas reaching statistical significance (P=0.023). In 2 patients with cricoid chondrosarcomas, the reconstruction was carried out using the Rethi-Ward technique, and they were without evidence of disease at 71 months (with no cannula) and 145 months (with cannula). Chondrosarcomas of the jugular foramen were treated using a modified infratemporal type A approach.
Conclusion:
Low grade head and neck chondrosarcomas have a good prognosis while high grade chondrosarcomas tend to recur, despite radical surgical treatment.
